DeutschNewstral
Article
timesofisrael.com on 2015-04-21 17:11
Teva offers to buy Mylan in $40 billion deal
Related news
Teva offers to buy Mylan for $40.1Bobserver-reporter.com
Teva offers to buy Mylan in $40B cash and stockThe Salt Lake Tribune
Teva Offers to Buy Mylan for $40 Billionwsj.com
Teva makes $40 billion offer to buy U.S. drug maker MylanHaaretz
Teva offers to buy Mylan in $40.1B cash-and-stock dealneworleanscitybusiness.com- Generic drugmaker Mylan offers to buy Perrigo for $29 billionHaaretz
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com- CTeva offers to buy drugmaker Mylan for $40.1Bcontracostatimes.com
Teva Hopes $40 Billion Mylan Deal Will Fuel Stock ReboundForbes
Reuters: Teva preparing to buy more Mylan sharesbizjournals.com- Mylan chief: Acquisition by Teva not feasibleHaaretz
Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com
Mylan rejects Teva’s $40 billion takeover bidtriblive.com
Teva Offers $40 Billion for MylanWHIO
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail- Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
- Mylan Rejects $40 Billion Teva Takeover Offer, Calls Stock 'Low-Quality'Forbes